PTC Therapeutics, Inc. Undistributed Earnings of Foreign Subsidiaries
PTC Therapeutics, Inc. (PTCT) had Undistributed Earnings of Foreign Subsidiaries of $654.30 million as of 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Income Taxes › Deferred Tax Liability Not Recognized, Undistributed Earnings of Foreign Subsidiaries
us-gaap:UndistributedEarningsOfForeignSubsidiaries · last filed 2026-02-19
- 2025-12-31: Undistributed Earnings of Foreign Subsidiaries $654.30M.
- 2024-12-31: Undistributed Earnings of Foreign Subsidiaries $425.30M.
- 2023-12-31: Undistributed Earnings of Foreign Subsidiaries $345.90M.
- 2022-12-31: Undistributed Earnings of Foreign Subsidiaries $65.10M.
| Period end | Undistributed Earnings of Foreign Subsidiaries |
|---|---|
| 2025-12-31 | $654.30M 10-K · filed 2026-02-19 |
| 2024-12-31 | $425.30M 10-K · filed 2025-02-27 |
| 2023-12-31 | $345.90M 10-K · filed 2024-02-29 |
| 2022-12-31 | $65.10M 10-K · filed 2023-02-21 |
| 2021-12-31 | $48.00M 10-K · filed 2022-02-22 |
| 2020-12-31 | $16.10M 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |